Single center analysis of therapy and outcomes of Hepatocellular carcinoma in Sub-Saharan Africa.
CONCLUSION: Our study found that antiviral treatment of HBV infection was associated with longer survival in HCC. Furthermore, Sorafenib was beneficial in patients that used this modality of treatment and the NLR was a good prognostic factor in those patients.
PMID: 32730120 [PubMed - as supplied by publisher]
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
More News: African Health | Cancer & Oncology | Carcinoma | Ethiopia Health | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Statistics | Study | Urology & Nephrology | Viread